BDBM50314237 CHEMBL1090992::rac-2-(5-(1-(2-hydroxy-3-((S)-2-methylpiperidin-1-yl)propyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-3-yl)-2-(trifluoromethyl)phenylthio)-1-morpholinoethanone

SMILES C[C@H]1CCCCN1CC(O)Cn1nc(c2CN(CCc12)S(C)(=O)=O)-c1ccc(c(SCC(=O)N2CCOCC2)c1)C(F)(F)F

InChI Key InChIKey=HCWXJCDBLQPFAD-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50314237   

TargetCathepsin S(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50314237(rac-2-(5-(1-(2-hydroxy-3-((S)-2-methylpiperidin-1-...)
Affinity DataIC50: 300nMAssay Description:Inhibition of human recombinant cathepsin S expressed in baculovirus expression sytem after 15 mins by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/18/2010
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50314237(rac-2-(5-(1-(2-hydroxy-3-((S)-2-methylpiperidin-1-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of cathepsin S in human JY cells assessed as accumulation of invariant chain p10li after 24 hrs by Western blot analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/18/2010
Entry Details Article
PubMed